TABLE 2—
Covariates | Total No. | HAART,a No. (%) | Suboptimal Treatment,b No. (%) | No ARV, No. (%) | P |
Total | 3259 | 1190 (36.5) | 855 (26.2) | 1214 (37.3) | |
Race/ethnicity | |||||
Non-Hispanic White | 457 | 228 (49.9) | 95 (20.8) | 134 (29.3) | <.01 |
Non-Hispanic Black | 2367 | 888 (37.5) | 701 (29.6) | 778 (32.9) | |
Hispanic | 346 | 51 (14.7) | 41 (11.9) | 254 (73.4) | |
Other | 89 | 23 (25.8) | 18 (20.2) | 48 (53.9) | |
Metro indexc | |||||
Large metro | 1662 | 553 (33.3) | 437 (26.3) | 672 (40.4) | <.01 |
Small metro | 1008 | 406 (40.3) | 257 (25.5) | 345 (34.2) | |
Nonmetro | 589 | 231 (39.2) | 161 (27.3) | 197 (33.5) | |
AIDS condition | |||||
Yes | 155 | 57 (36.8) | 46 (29.7) | 52 (33.6) | .51 |
No | 3104 | 1133 (36.5) | 809 (26.1) | 1162 (37.4) | |
Comorbidity | |||||
Yes | 1231 | 431 (35.0) | 356 (28.9) | 444 (36.1) | .02 |
No | 2028 | 759 (37.4) | 499 (24.6) | 770 (38.0) | |
Cesarean delivery | |||||
Yes | 1824 | 695 (38.1) | 506 (27.7) | 623 (34.2) | <.1 |
No | 1435 | 495 (34.5) | 349 (24.3) | 591 (41.2) | |
Months enrolled in Medicaidd | |||||
< 3 mo | 260 | 7 (2.7) | 6 (2.3) | 247 (95.0) | <.01 |
≥ 3 mo | 2999 | 1183 (39.5) | 849 (28.3) | 967 (32.2) |
Note. ARV = antiretroviral therapy; HAART = highly active antiretroviral therapy.
HAART included at least 1 nucleoside reverse-transcriptase inhibitor and at least 2 other agents.
Suboptimal treatment = some or any ARV treatment prescription other than HAART.
Large metro = metropolitan area with 1 million residents or more; small metro = metropolitan area with fewer than 1 million residents; nonmetro = rural area.
Eligible months over 3 years of Medicaid claim data.